Tag: Psychedelic Medicine

A growing group of companies is developing pharmaceutical-grade psilocybin from mushrooms, creating the infrastructure needed to investigate whether the broader ...

Entropy Neurodynamics has reported sustained improvements in treatment-resistant binge-eating disorder three months after patients received two infusions of its IV ...

Long before psilocybin was being studied in hospitals and universities, and decades before psychedelic medicine became a commercial industry, an ...

Emyria (ASX: EMD) is preparing to open its first Sydney clinic in September, with the company saying key operational milestones ...

New Zealand has authorised two psychiatrists to prescribe pharmaceutical-grade MDMA as part of supervised treatment for adults with post-traumatic stress ...

BLS Pharmaceuticals Limited (ASX: BLS) has appointed Zivana Crestani as Strategic Partnership Director, adding to the company's commercial leadership as ...

Ensysce Biosciences will participate in the U.S. Food and Drug Administration's September 14 public hearing on the potential future therapeutic ...

With six weeks to go until SCALE 2026, the international mental health and psychedelic medicine community is preparing to gather ...

Australia's listed cannabis sector has become increasingly difficult to define simply as "cannabis". The latest results show companies moving in ...

BLS Pharmaceuticals (ASX: BLS) has reported a record FY26, with revenue climbing 161% to $74.2 million and Adjusted EBITDA rising ...